{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:34:43Z","timestamp":1775784883630,"version":"3.50.1"},"reference-count":24,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,9]]},"DOI":"10.1182\/blood.2019003236","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T20:09:56Z","timestamp":1579896596000},"page":"1299-1302","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic bone marrow biopsy in patients with stage I EMZL treated with radiation therapy: needed or not?"],"prefix":"10.1182","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-3377","authenticated-orcid":false,"given":"Juan Pablo","family":"Alderuccio","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Isrow","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isildinha M.","family":"Reis","sequence":"first","affiliation":[{"name":"Department of Public Health Science,"},{"name":"Biostatistics and Bioinformatics Core Resource,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Girish","family":"Iyer","sequence":"first","affiliation":[{"name":"Division of Internal Medicine, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica J.","family":"Meshman","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"first","affiliation":[{"name":"Biostatistics and Bioinformatics Core Resource,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"first","affiliation":[{"name":"Division of Hematopathology, Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Chapman","sequence":"first","affiliation":[{"name":"Division of Hematopathology, Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold M.","family":"Markoe","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9013","authenticated-orcid":false,"given":"Izidore S.","family":"Lossos","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine,"},{"name":"Department of Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"16","key":"2020040911580092300_B1","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"2020040911580092300_B2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijrobp.2013.11.225","article-title":"Radiation therapy administration and survival in stage I\/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"88","author":"Olszewski","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2020040911580092300_B3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2020040911580092300_B4","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"issue":"22","key":"2020040911580092300_B5","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020040911580092300_B6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"2020040911580092300_B7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2007.04.029","article-title":"A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG)","volume":"69","author":"Isobe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2020040911580092300_B8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020040911580092300_B9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2005.1.307","article-title":"Clinical presentation and management of marginal zone lymphomas","volume":"2005","author":"Thieblemont","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2020040911580092300_B10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"issue":"11","key":"2020040911580092300_B11","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"11","key":"2020040911580092300_B12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"36","key":"2020040911580092300_B13","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","article-title":"Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with Hodgkin lymphoma","volume":"30","author":"El-Galaly","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020040911580092300_B14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","article-title":"FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis","volume":"41","author":"Adams","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"26","key":"2020040911580092300_B15","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1200\/JCO.2010.32.4996","article-title":"[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin\u2019s lymphoma","volume":"29","author":"Purz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020040911580092300_B16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdt533","article-title":"Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?","volume":"25","author":"Adams","year":"2014","journal-title":"Ann Oncol"},{"key":"2020040911580092300_B17","unstructured":"National Comprehensive Cancer Network\n          . B-cell lymphomas (version 4.2019). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf. Accessed 5 August 2019."},{"issue":"4","key":"2020040911580092300_B18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol"},{"key":"2020040911580092300_B19","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"Revised 4th ed"},{"key":"2020040911580092300_B20","doi-asserted-by":"crossref","DOI":"10.1002\/9780470870709","volume-title":"Competing risks: a practical perspective","author":"Pintilie","year":"2006"},{"issue":"446","key":"2020040911580092300_B21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2020040911580092300_B22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2020040911580092300_B23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"2020040911580092300_B24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/15\/1299\/1723167\/bloodbld2019003236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/15\/1299\/1723167\/bloodbld2019003236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T16:04:53Z","timestamp":1586448293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/15\/1299\/440746\/Diagnostic-bone-marrow-biopsy-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019003236","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]}}}